ITGAX and pancreatic neoplasm: Recent investigations have revealed the significant involvement of CD11c+ monocytes in the early metastatic process of pancreatic cancer (54), aligning with our own research findings (ORIVW=1.105, 95%CI=1.002–1.218) (Figure 3A).